Search results for "CQ"

showing 10 items of 1801 documents

"Table 1" of "First measurement of the production of a W boson in association with a single charm quark in p anti-p collisions at s**(1/2) = 1.96-TeV"

2009

The measured cross section for leptonic decay of the W.

InclusiveHigh Energy Physics::PhenomenologyIntegrated Cross SectionPBAR P --> W- CQ XHigh Energy Physics::ExperimentCross SectionSIG1960.0W ProductionPBAR P --> W+ CQBAR X
researchProduct

"Table 4" of "Measurement of $\gamma$ + b + X and $\gamma$ + c + X production cross sections in $p \bar{p}$ collisions at $\sqrt{s}$=1.96 TeV"

2009

Differential cross section for (GAMMA CJET X) production in the region YRAP(GAMMA)*YRAP(JET) < 0.

InclusiveRapidity DependenceTriple Differential Cross SectionJet ProductionD3SIG/DPT/DYRAP/DYRAPTransverse Momentum Dependence1960.0PBAR P --> GAMMA JET XPBAR P --> GAMMA CQ X
researchProduct

"Table 3" of "Measurement of $\gamma$ + b + X and $\gamma$ + c + X production cross sections in $p \bar{p}$ collisions at $\sqrt{s}$=1.96 TeV"

2009

Differential cross section for (GAMMA CJET X) production in the region YRAP(GAMMA)*YRAP(JET) > 0.

InclusiveRapidity DependenceTriple Differential Cross SectionJet ProductionD3SIG/DPT/DYRAP/DYRAPTransverse Momentum Dependence1960.0PBAR P --> GAMMA JET XPBAR P --> GAMMA CQ X
researchProduct

"Table 2" of "The Forward - backward asymmetry for charm quarks at the Z pole"

1995

No description provided.

InclusiveSIN2TWAsymmetry MeasurementCharm productionE+ E- ScatteringE+ E- --> CQBAR CQE+ E- --> ZExclusiveE+ E- --> D*(2010)- X91.2E+ E- --> D*(2010)+ XASYM
researchProduct

"Table 1" of "A measurement of alpha(s) from the scaling violation in e+ e- annihilation."

1996

SIG(Q=BQ, Q=CQ, Q=UDS) corresponds to BQ, CQ, and U,D,S quarks fragmentation into charged hadron.

InclusiveSingle Differential Cross SectionE+ E- --> DQBAR DQE+ E- --> SQBAR SQE+ E- ScatteringE+ E- --> CQBAR CQE+ E- --> BQBAR BQE+ E- --> UQBAR UQExclusive91.2DSIG/DXE+ E- --> CHARGED-HADRON X
researchProduct

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials…

2019

Pardo-Oviedo, Juan Mauricio/0000-0003-0084-3449; Lopez-Delgado, Juan Carlos/0000-0003-3324-1129; Corradi, Francesco/0000-0002-5588-2608; De Backer, Daniel/0000-0001-9841-5762; POTA, VINCENZO/0000-0001-9999-3388; Tomescu, Dana/0000-0001-9673-5754; Sabetian, Golnar/0000-0001-8764-2150; Girardis, Massimo/0000-0002-2453-0829; Brazzi, Luca/0000-0001-7059-0622; Leone, Marc/0000-0002-3097-758X; Zabolotskikh, Igor Borisovich/0000-0002-3623-2546; De Lange, Dylan/0000-0002-0191-7270; ALMEKHLAFI, GHALEB A./0000-0002-0323-7025; Elke, Gunnar/0000-0002-4948-1605; Grigoras, Ioana/0000-0001-9412-9574; Czuczwar, Miroslaw/0000-0002-9025-6717; Nora, David/0000-0002-1133-7368; Masjedi, Mansoor/0000-0001-6175-9…

Infection riskMaleBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.Antibiotic resistanceTracte gastrointestinal - MalaltiesDefinitionsCritical Care and Intensive Care MedicineTHERAPYDEFINITIONS:Infections::Intraabdominal Infections [DISEASES]0302 clinical medicineIntensive care; Intra-abdominal infection; Mortality; Multidrug resistance; Peritonitis; Sepsis;[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesObservational studySeptic shockIntensive care; Intra-abdominal infection; Mortality; Multidrug resistance; Peritonitis; SepsisComputingMilieux_MISCELLANEOUSCritical Illness/epidemiology[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseasesBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti.Intraabdominal Infections/epidemiologyAbdominal infectionMulticenter study3. Good healthManagementClinical trialCohort[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyCohort analysisCommunity acquired infectionCohort studyHumanmedicine.medical_specialtyCarbapenem resistanceCritical IllnessPeritoneal dialysisPeritonitisVancomycin resistant enterococcusMajor clinical studyPeritonitisArticle03 medical and health sciencesAntibiotic resistance[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemIntensive careSepsisSettore MED/41 - ANESTESIOLOGIAHumansCritical care medicineHospital infectionAgedScience & TechnologyLiver failureAntibiotic therapymedicine.disease[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyEpidemiologic Studies030228 respiratory systemIntensive Care Unit; Sepsis (Diptera); Septic ShockRisk factorHuman medicineGeneral & internal medicineCongestive heart failureOriginalMultidrug resistanceCohort StudiesRisk FactorsCause of DeathEpidemiologyPrevalenceMedicine and Health SciencesAbdominal abscessSepsis/epidemiologyMiddle agedAntifungal therapy2. Zero hungerPeritonitiAntibiotic agentBiliary tract infectionIntensive care ; Intra-abdominal infection ; Mortality ; Multidrug resistance ; Peritonitis ; SepsisMiddle Aged:infecciones bacterianas y micosis::infección::infecciones intraabdominales [ENFERMEDADES]PREVALENCE:Infections::Sepsis [DISEASES]:técnicas de investigación::métodos epidemiológicos::características de los estudios epidemiológicos::estudios epidemiológicos::estudios de cohortes [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Methicillin resistant staphylococcus aureusRaonament basat en casosFemaleCritically ill patientLife Sciences & BiomedicineAntifungal agentAdult:Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics::Epidemiologic Studies::Cohort Studies [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Predictive value:infecciones bacterianas y micosis::infección::sepsis [ENFERMEDADES]NOSepsisIntra-abdominal infectionCritical Care MedicineInternal medicineGeneral & Internal MedicinemedicineMANAGEMENTJournal Article[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologySepticèmiaMortalitybusiness.industrySeptic shockPancreas diseaseMalnutrition030208 emergency & critical care medicineTyphlitisToxic megacolonIntensive careIntraabdominal InfectionsTherapyLate onset disorderbusiness
researchProduct

Exploring a regulatory role for mast cells: 'MCregs'?

2010

Regulatory cells can mould the fate of the immune response by direct suppression of specific subsets of effector cells, or by redirecting effectors against invading pathogens and infected or neoplastic cells. These functions have been classically, although not exclusively, ascribed to different subsets of T cells. Recently, mast cells have been shown to regulate physiological and pathological immune responses, and thus to act at the interface between innate and adaptive immunity assuming different functions and behaviors at discrete stages of the immune response. Here, we focus on these poorly defined, and sometimes apparently conflicting, functions of mast cells.

InflammationEffectorMast cell; Regulatory cells; cell-cell crosstalkImmunologyRegulatory cellModels ImmunologicalAutoimmunityAdaptive ImmunityBiologybiochemical phenomena metabolism and nutritionAcquired immune systemT-Lymphocytes RegulatoryImmunity InnateClassical complement pathwaycell-cell crosstalkImmune systemRegulatory cellsNeoplasmsImmunologyImmune ToleranceMAST CELLAnimalsHumansImmunology and AllergyMast Cells
researchProduct

Complement and atherosclerosis—united to the point of no return?

2012

Atherosclerosis is widely regarded as a chronic inflammatory disease that develops as a consequence of entrapment of oxidized low-density lipoprotein (LDL) in the arterial intima and its interaction with components of both innate and adaptive immunity. This article reviews the role of the complement system in the context of a different concept on atherogenesis. Arguments are forwarded in support of the contention that enzymatic and not oxidative modification of LDL is the prerequisite for transforming the lipoprotein into a moiety that is recognized by the innate immune system. In a departure from general wisdom, it is proposed that these processes are initially not pathological. To the con…

InflammationInnate immune systemClinical BiochemistryContext (language use)InflammationComplement System ProteinsGeneral MedicineBiologyAtherosclerosisAcquired immune systemComplement systemLipoproteins LDLC-Reactive ProteinCholesterolImmune systemImmunologymedicineHumansMacrophagemedicine.symptomComplement ActivationFoam CellsFoam cellClinical Biochemistry
researchProduct

miR-155: On the Crosstalk Between Inflammation and Cancer

2009

MicroRNAs are short non-coding RNAs that posttranscriptionally modulate the expression of multiple target genes and are thus implicated in a wide array of cellular and developmental processes. miR-155 is processed from BIC, a non-coding transcript highly expressed in both activated B and T cells and in monocytes/macrophages. miR-155 levels change dynamically during both hematopoietic lineage differentiation and the course of the immune response. Different mouse models developed recently indicate that miR-155 plays a critical role during hematopoiesis and regulates lymphocyte homeostasis and tolerance. A moderate increase of miR-155 levels is observed in many types of malignancies of B cell …

InflammationRegulation of gene expressionInnate immune systemMyeloidImmunologyGene ExpressionBiologyAcquired immune systemCell biologymiR-155MiceMicroRNAsmedicine.anatomical_structureImmune systemGene Expression RegulationNeoplasmsLymphocyte homeostasisImmunologymedicineAnimalsHumansImmunology and AllergyB cellInternational Reviews of Immunology
researchProduct

Analysis and modulation of the inflammatory response through lung agression related to bacterial infection and mechanical ventilation

2015

Despite major advances since decades in the management of ventilated patients, ventilator-associated pneumonia (VAP) continues to complicate the course of approximately 28% of the patients receiving mechanical ventilation (MV). Among patients hospitalized in intensive care units, the risk of pneumonia is 3- to 10- fold increased in MV patients. However, MV is often the only way to care for critically ill patients with respiratory failure. It has now been clearly demonstrated that MV, in particular adverse ventilatory strategies could activate lung cells, thus leading to a proinflammatory response, even in the absence of pathogen. This is the biotrauma paradigm, which accounts, at least in p…

InflammationVentilation mécaniqueLésions pulmonairesStatinsPneumonie acquise sous ventilation mécaniquePneumonia[SDV.BC]Life Sciences [q-bio]/Cellular BiologyLung injuryStatinesProne positionMechanical ventilationDécubitus ventralAlarminesPneumonieAlarminsVentilator-associated pneumoniaInfection[SDV.BC] Life Sciences [q-bio]/Cellular Biology
researchProduct